Drug Shortage Report for LABETALOL HYDROCHLORIDE INJECTION, USP

Last updated on 2019-09-11 History
Report ID 78454
Drug Identification Number 02387468
Brand name LABETALOL HYDROCHLORIDE INJECTION, USP
Common or Proper name LABETALOL HYDROCHLORIDE INJECTION, USP
Company Name MYLAN PHARMACEUTICALS ULC
Active Ingredient(s) LABETALOL HYDROCHLORIDE
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 20ML 1VL
ATC code C07AG
ATC description BETA BLOCKING AGENTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2019-09-10
Actual start date
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2019-09-11
Company comments ID 10718 was resolved in error on Mar-8-2019. Reopened in this ID.
Health Canada comments
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v58 2019-09-11 English Compare
v57 2019-09-03 French Compare
v56 2019-09-03 English Compare
v55 2019-08-30 French Compare
v54 2019-08-30 English Compare
v53 2019-08-30 English Compare
v52 2019-08-23 French Compare
v51 2019-08-23 English Compare
v50 2019-08-15 English Compare
v49 2019-08-14 French Compare
v48 2019-08-14 English Compare
v47 2019-08-08 English Compare
v46 2019-08-07 French Compare
v45 2019-08-07 English Compare
v44 2019-07-31 English Compare
v43 2019-07-29 French Compare
v42 2019-07-29 English Compare
v41 2019-07-25 English Compare
v40 2019-07-23 French Compare
v39 2019-07-23 English Compare

Showing 1 to 20 of 58